Insights On Partnering

  1. Top 10 Global Pharma Company Dramatically Improves Site Payments In Drive To Become Sponsor Of Choice 10/30/2024

    See how a pharma company reduced investigator payment cycle time by 55% while decreasing their own administrative burden by 90% in this metrics-rich case study.

  2. The Role Of Company Culture In FSP Partnerships 8/1/2025

    This piece explores intentional culture-building as a strategic asset in FSP engagements, transforming transactional relationships into enduring, high-performing partnerships.

  3. Stipends Create More Tax Burden — Here's A Better Option 7/22/2025

    Explore the tax reporting requirements, including the threshold for payments requiring a 1099 form rising from $600 to $2,000 in 2026.

  4. Why Functional Outsourcing Is Important To Clinical Development 8/1/2025

    Craig McIlloney, Senior Vice President of Worldwide Flex, discusses why functional outsourcing is important in today's clinical development environment, how Worldwide Flex supports this, and is scalable to flex to your changing needs.

  5. Finding The Right CRO Partner For Early-Stage Oncology Trials 11/21/2025

    Discover how a data-driven CRO selection framework can replace manual processes, minimize bias, and build stronger, more collaborative sponsor–vendor relationships.

  6. The High Cost Of CRO Turnover (And How You Can Avoid It) 9/18/2024

    Though some turnover is an inevitable part of a business’s life cycle, there are several strategies available to ensure a consistent CRO team throughout the span of your trial.

  7. Paperless Online Remote Source Document Verification 2/2/2026

    Learn how Clinical Trial Organizations, Monitoring Teams and Clinical Sites can benefit from the way Judi transforms rSDV from a logistical hurdle into a strategic asset.

  8. Taking Research In-House With CRIO: SciTech's Multi-Center Phase 1 Study 1/6/2025

    Explore the success story of an early-stage clinical pharmaceutical company that effectively navigated funding constraints when conducting its Phase 1 study without a third-party CRO. 

  9. TPDs: Developing The Next Generation Of Oral Therapeutics 10/20/2025

    Targeted Protein Degraders are a revolutionary drug class with challenges in bioavailability and formulation complexity. Strategic CDMO partnerships are key to successful, scalable development.

  10. Modernizing Clinical Trial Logistics To Deliver Value 2/3/2026

    Explore how biopharma organizations can design and operate clinical supply systems that absorb complexity while maintaining control and consistency.